Alcohol Use and the Risk of Colorectal Liver Metastasis: A Systematic Mapping Review.
alcohol use
alcohol-associated liver disease
colorectal carcinoma
colorectal liver metastasis
mapping review
Journal
Biology
ISSN: 2079-7737
Titre abrégé: Biology (Basel)
Pays: Switzerland
ID NLM: 101587988
Informations de publication
Date de publication:
06 Feb 2023
06 Feb 2023
Historique:
received:
05
01
2023
revised:
31
01
2023
accepted:
02
02
2023
entrez:
25
2
2023
pubmed:
26
2
2023
medline:
26
2
2023
Statut:
epublish
Résumé
The consumption of alcohol has long been associated with the development of liver disease as well as cancers including colorectal cancer (CRC). Leading healthcare concerns include the prevalent use of alcohol and the high burden of CRC mortality. Many CRC deaths are attributed to the development of colorectal liver metastasis (CRLM) as the liver is the foremost site of CRC spread. However, an association has not been defined for the role of alcohol intake and related liver injury with the development of CRLM. Here, a mapping review of recent research was undertaken to evaluate the relationship between alcohol consumption and the risk of CRLM. The literature search revealed 14 articles meeting the inclusion criteria that included patient database analyses and preclinical studies. Most of the human data analyses found alcohol use independently associates with worse CRC outcomes. The preclinical evaluations identified several pathways involved in the alcohol-mediated promotion of CRLM burden and CRC cell metastatic behavior. The limited number of studies identified exposes a significant need for more prospective analyses to define the role of alcohol intake and advanced CRC as well as the translation of preclinical research to fully characterize targetable mechanisms for the generation of new therapeutic options.
Identifiants
pubmed: 36829534
pii: biology12020257
doi: 10.3390/biology12020257
pmc: PMC9953220
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : VA Office of Research and Development
ID : BX004127
Références
Am J Clin Nutr. 2016 Jan;103(1):192-200
pubmed: 26607936
Eur J Cancer Prev. 2014 Nov;23(6):532-9
pubmed: 25170915
Am J Public Health. 2013 Apr;103(4):641-8
pubmed: 23409916
IARC Monogr Eval Carcinog Risks Hum. 2010;96:3-1383
pubmed: 21735939
Cancer. 1998 Oct 15;83(8):1483-8
pubmed: 9781941
Alcohol Alcohol. 2011 Nov-Dec;46(6):709-13
pubmed: 21949190
Int J Clin Exp Med. 2015 May 15;8(5):6878-89
pubmed: 26221225
Ann Oncol. 2011 Sep;22(9):1958-1972
pubmed: 21307158
Int J Cancer. 2020 Feb 1;146(3):861-873
pubmed: 31037736
Cancers (Basel). 2019 Apr 10;11(4):
pubmed: 30974805
J Epidemiol. 2010;20(3):204-11
pubmed: 20234107
Am J Epidemiol. 2011 Nov 1;174(9):1044-53
pubmed: 21965184
Cell Mol Gastroenterol Hepatol. 2017 Jan 20;3(2):163-173
pubmed: 28275683
Am J Clin Nutr. 2016 Jun;103(6):1497-506
pubmed: 27146651
Front Oncol. 2020 Dec 09;10:607909
pubmed: 33363037
Nutr Cancer. 2007;59(1):36-45
pubmed: 17927500
Sci Rep. 2018 Jun 5;8(1):8640
pubmed: 29872080
Cancer. 2017 May 15;123(6):1035-1043
pubmed: 27861761
Drug Alcohol Depend. 2015 Nov 1;156:1-13
pubmed: 26371405
Br J Cancer. 2006 Jul 3;95(1):21-6
pubmed: 16804525
Clin Exp Metastasis. 2017 Feb;34(2):171-184
pubmed: 28168393
World J Gastroenterol. 2014 Apr 14;20(14):3719-37
pubmed: 24744570
EBioMedicine. 2019 Dec;50:224-237
pubmed: 31757777
Alcohol. 2021 Nov;96:37-42
pubmed: 34245809
Res Commun Chem Pathol Pharmacol. 1973 Nov;6(3):983-91
pubmed: 4796840
Cancer. 2014 May 15;120(10):1540-7
pubmed: 24591061
Alcohol Res Health. 2003;27(1):95-109
pubmed: 15301404
Sci Rep. 2019 Oct 21;9(1):15077
pubmed: 31636296
CA Cancer J Clin. 2020 May;70(3):145-164
pubmed: 32133645
Cancer Res. 2016 Apr 1;76(7):1698-704
pubmed: 26857263
Mol Carcinog. 2016 May;55(5):1002-11
pubmed: 26014148
Asian Pac J Cancer Prev. 2013;14(2):909-13
pubmed: 23621260
Phys Ther. 2009 Sep;89(9):873-80
pubmed: 19723669
Clin Colon Rectal Surg. 2009 Nov;22(4):191-7
pubmed: 21037809
Hepatology. 2022 Jun;75(6):1480-1490
pubmed: 34878683